HealthRegulation
FDA Panel Backs Broader Access to Gray Market Peptides
FDA panel voted to ease restrictions on six peptides, allowing compounding pharmacies to produce them and potentially curbing the unregulated gray market.
—5 min read
Tag
1 article
FDA panel voted to ease restrictions on six peptides, allowing compounding pharmacies to produce them and potentially curbing the unregulated gray market.